Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin

Digoxin is widely used to treat heart failure. Epidemiological studies suggested it might be used as an anticancer drug or sensitizing agent for cancer therapy. Adriamycin is a well-known anticancer drug, but often causes cardiotoxicity which limits its use. We recently investigated the anticancer e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Wang, Yingying, Ma, Qian, Zhang, Shaolu, Liu, Hongyan, Zhao, Baoquan, Du, Bo, Wang, Wei, Lin, Peng, Zhang, Zhe, Zhong, Yuxu, Kong, Dexin
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7059749/
https://ncbi.nlm.nih.gov/pubmed/32180730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00186
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados